USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
GEL-DEL TECHNOLOGIES, INC.
Address:
1000 WESTGATE DRIVE
ST. PAUL, MN
Phone:
N/A
URL:
N/A
EIN:
141193080
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $599,794.00 2
SBIR Phase II $5,494,163.00 2

Award List:

Arterial-Mimetic Grants Molded from Purified Proteins

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$149,800.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The development of an alternative to the currently available synthetic vascular prosthesis is of great value. Atherosclerosis vascular disease, in the form of coronary artery and peripheral vascular disease, is the leading cause of mortality in the United States.… More

Arterial-Mimetic Grafts Molded from Purified Proteins

Award Year / Program / Phase:
2006 / SBIR / Phase II
Award Amount:
$2,057,869.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Atherosclerotic vascular disease, in the form of coronary artery and peripheral vascular disease, is the leading cause of mortality in the United States. Despite vast improvements in the field of biomaterials, a useful biocompatible material is still not… More

Arterial-Mimetic Grafts Molded from Purified Proteins

Award Year / Program / Phase:
2009 / SBIR / Phase II
Award Amount:
$3,436,294.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Peripheral artery disease and trauma are leading causes of morbidity and amputation in the United States. Recent advances in biomaterials provide for potential development of small diameter vascular grafts as a life-sav ing treatment. Development of a life-long… More

Non-Clotting Micro-Catheter for Newborns

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$449,994.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Pre-mature and critically ill infants often require frequent medication and nutrient administration, necessitating use of peripheral intravenous catheters for prolonged periods. Due to the small diameter of these newbor ns' veins, these catheters demonstrate a… More